Heron Net Income Applicable To Common Shares from 2010 to 2026

HRTX Stock  USD 1.15  0.02  1.71%   
Heron Therapeuti Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to about -172 M in 2026. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2000-03-31
Previous Quarter
-42.1 M
Current Value
-25 M
Quarterly Volatility
22.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 7.3 M or Total Revenue of 174.2 M, as well as many indicators such as Price To Sales Ratio of 1.38, Dividend Yield of 0.0 or Days Sales Outstanding of 109. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Build AI portfolio with Heron Stock
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.
The evolution of Net Income Applicable To Common Shares for Heron Therapeuti provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Heron Therapeuti compares to historical norms and industry peers.

Latest Heron Therapeuti's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Heron Therapeuti over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Heron Therapeuti's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Heron Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(137,828,722)
Geometric Mean97,539,300
Coefficient Of Variation(55.98)
Mean Deviation66,819,686
Median(173,143,000)
Standard Deviation77,154,795
Sample Variance5952.9T
Range232.7M
R-Value(0.80)
Mean Square Error2303T
R-Squared0.64
Significance0.0001
Slope(12,197,399)
Total Sum of Squares95245.8T

Heron Net Income Applicable To Common Shares History

2026-172 M
2025-163.8 M
2022-182 M
2021-220.7 M
2020-227.3 M
2019-204.7 M
2018-178.8 M

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-163.8 M-172 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.